Umban, Venerando S.
HRN: 26-27-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2025
CEFTRIAXONE 1G (VIAL)
11/10/2025
11/17/2025
IV
2 Grams
Od
Non Healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes